Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 3
1951 1
1955 1
1999 1
2002 1
2012 2
2013 6
2014 17
2015 23
2016 26
2017 24
2018 36
2019 44
2020 33
2021 26
2022 34
2023 34
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Foreword.
Lapa C, Bundschuh RA. Lapa C, et al. Nuklearmedizin. 2022 Jun;61(3):222. doi: 10.1055/a-1819-9945. Epub 2022 Jun 3. Nuklearmedizin. 2022. PMID: 35668667 No abstract available.
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Hummel HD, Kufer P, Grüllich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Döcke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC. Hummel HD, et al. Among authors: lapa c. Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10. Immunotherapy. 2021. PMID: 33172323 Clinical Trial.
Response.
Emmanuel A, Lapa C, Ghosh A, Gulati S, Burt M, Hayee B, Haji A. Emmanuel A, et al. Among authors: lapa c. Gastrointest Endosc. 2019 Sep;90(3):542. doi: 10.1016/j.gie.2019.05.017. Gastrointest Endosc. 2019. PMID: 31439145 No abstract available.
Infection and Inflammation Imaging: Beyond FDG.
Kircher M, Lapa C. Kircher M, et al. Among authors: lapa c. PET Clin. 2020 Apr;15(2):215-229. doi: 10.1016/j.cpet.2019.11.004. Epub 2020 Feb 11. PET Clin. 2020. PMID: 32145892 Review.
In Vivo Targeting of CXCR4-New Horizons.
Schottelius M, Herrmann K, Lapa C. Schottelius M, et al. Among authors: lapa c. Cancers (Basel). 2021 Nov 25;13(23):5920. doi: 10.3390/cancers13235920. Cancers (Basel). 2021. PMID: 34885030 Free PMC article. Review.
CXCR4-directed theranostics in oncology and inflammation.
Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C. Kircher M, et al. Among authors: lapa c. Ann Nucl Med. 2018 Oct;32(8):503-511. doi: 10.1007/s12149-018-1290-8. Epub 2018 Aug 13. Ann Nucl Med. 2018. PMID: 30105558 Free PMC article. Review.
[Diagnostics in osteology].
Jakob F, Genest F, Seefried L, Tsourdi E, Lapa C, Hofbauer LC. Jakob F, et al. Among authors: lapa c. Internist (Berl). 2016 Jul;57(7):631-7. doi: 10.1007/s00108-016-0081-3. Internist (Berl). 2016. PMID: 27307159 Review. German.
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer.
Rowe SP, Buck A, Bundschuh RA, Lapa C, Serfling SE, Derlin T, Higuchi T, Gorin MA, Pomper MG, Werner RA. Rowe SP, et al. Among authors: lapa c. Nuklearmedizin. 2022 Jun;61(3):240-246. doi: 10.1055/a-1659-0010. Epub 2022 Jan 14. Nuklearmedizin. 2022. PMID: 35030637 Free article. Review. English.
CXCR4 Ligands: The Next Big Hit?
Walenkamp AME, Lapa C, Herrmann K, Wester HJ. Walenkamp AME, et al. Among authors: lapa c. J Nucl Med. 2017 Sep;58(Suppl 2):77S-82S. doi: 10.2967/jnumed.116.186874. J Nucl Med. 2017. PMID: 28864616 Free article. Review.
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy.
Steinhelfer L, Lunger L, Cala L, Pfob CH, Lapa C, Hartrampf PE, Buck AK, Schäfer H, Schmaderer C, Tauber R, Brosch-Lenz J, Haller B, Meissner VH, Knorr K, Weber WA, Eiber M. Steinhelfer L, et al. Among authors: lapa c. J Nucl Med. 2024 Jan 2;65(1):79-84. doi: 10.2967/jnumed.123.265986. J Nucl Med. 2024. PMID: 37857504
288 results